carvedilol has been researched along with Blood Pressure, Low in 22 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Data were retrospectively collected from 23 patients with HF [age 57±18 years, left ventricular ejection fraction (LVEF) 33±15%] who could not increase the dosage of carvedilol because of dizziness or hypotension, defined as systolic blood pressure<90 mmHg." | 7.79 | Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension. ( Asano, Y; Ichibori, Y; Kanzaki, M; Komuro, I; Minamiguchi, H; Mizote, I; Ohtani, T; Sakata, Y; Taniguchi, T, 2013) |
| "A 54-year-old white man with severe heart failure was placed on carvedilol 3." | 7.70 | Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol. ( Bristow, MR; Lindenfeld, J; Lowes, BD, 1999) |
| "beta-blockers (BB) in the treatment of heart failure (HF) are frequently underprescribed and underdosed, perhaps because of recommendations for office visits at each dose change." | 5.32 | Remote titration of carvedilol for heart failure patients by advanced practice nurses. ( Mischke, L; Moyer-Knox, D; Mueller, TM; Vuckovic, K; Williams, RE, 2004) |
| "Data were retrospectively collected from 23 patients with HF [age 57±18 years, left ventricular ejection fraction (LVEF) 33±15%] who could not increase the dosage of carvedilol because of dizziness or hypotension, defined as systolic blood pressure<90 mmHg." | 3.79 | Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension. ( Asano, Y; Ichibori, Y; Kanzaki, M; Komuro, I; Minamiguchi, H; Mizote, I; Ohtani, T; Sakata, Y; Taniguchi, T, 2013) |
| "A 54-year-old white man with severe heart failure was placed on carvedilol 3." | 3.70 | Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol. ( Bristow, MR; Lindenfeld, J; Lowes, BD, 1999) |
| "Beta-blockers substantially improve survival in patients with chronic heart failure (HF) with left ventricular systolic dysfunction, but concerns about cardiovascular adverse effects may deter physicians from prescribing this therapy." | 2.71 | Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. ( Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A, 2004) |
| "Flushing and erythema are frequent skin symptoms in rosacea." | 2.66 | Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action. ( Driessen, RJB; Logger, JGM; Olydam, JI, 2020) |
| " Beta-blocker dosages were titrated, and three patients achieved the target beta-blocker dosage established for stage A-C heart failure." | 1.34 | Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone. ( Earl, GL; Fitzpatrick, JM; Narula, J; Verbos-Kazanas, MA, 2007) |
| "beta-blockers (BB) in the treatment of heart failure (HF) are frequently underprescribed and underdosed, perhaps because of recommendations for office visits at each dose change." | 1.32 | Remote titration of carvedilol for heart failure patients by advanced practice nurses. ( Mischke, L; Moyer-Knox, D; Mueller, TM; Vuckovic, K; Williams, RE, 2004) |
| "Carvedilol is a non selective beta-adrenoceptor antagonist which also causes peripheral vasodilation primarily via alpha 1-adrenergic blockade (Strein et al." | 1.30 | Carvedilol overdose. ( Hantson, P; Lambermont, JY; Mahieu, P; Simoens, G, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Groszek, G | 1 |
| Bednarski, M | 1 |
| Dybała, M | 1 |
| Filipek, B | 1 |
| Nadal, MÁ | 1 |
| Viera Ramírez, ER | 1 |
| García Vallejo, M | 1 |
| Martín Capón, I | 1 |
| Fernández Lucas, M | 1 |
| Stone, KH | 1 |
| Reynolds, K | 1 |
| Davis, S | 1 |
| Van Tassell, BW | 1 |
| Gibson, CM | 1 |
| Logger, JGM | 1 |
| Olydam, JI | 1 |
| Driessen, RJB | 1 |
| Taniguchi, T | 1 |
| Ohtani, T | 1 |
| Mizote, I | 1 |
| Kanzaki, M | 1 |
| Ichibori, Y | 1 |
| Minamiguchi, H | 1 |
| Asano, Y | 1 |
| Sakata, Y | 1 |
| Komuro, I | 1 |
| Nakamura, K | 1 |
| Fukami, N | 1 |
| Nabeta, T | 1 |
| Inomata, T | 1 |
| Iida, Y | 1 |
| Ikeda, Y | 1 |
| Iwamoto-Ishida, M | 1 |
| Ishii, S | 1 |
| Naruke, T | 1 |
| Mizutani, T | 1 |
| Shinagawa, H | 1 |
| Koitabashi, T | 1 |
| Takeuchi, I | 1 |
| Ako, J | 1 |
| Steib, CJ | 1 |
| Gerbes, AL | 1 |
| Forrester, MB | 1 |
| Nabbi, R | 1 |
| Riess, ML | 1 |
| Woehlck, HJ | 1 |
| Cohen-Solal, A | 1 |
| Logeart, D | 1 |
| Guiti, C | 1 |
| Bourgoin, P | 1 |
| Watanabe, K | 1 |
| Abe, Y | 1 |
| Sato, S | 1 |
| Wahed, M | 1 |
| Wen, J | 1 |
| Narasimman, G | 1 |
| Ma, M | 1 |
| Ali, F | 1 |
| Saito, Y | 1 |
| Suresh, P | 1 |
| Shirai, K | 1 |
| Soga, M | 1 |
| Nagai, Y | 1 |
| Takahashi, T | 1 |
| Hasegawa, G | 1 |
| Naito, M | 1 |
| Tachikawa, H | 1 |
| Tanabe, N | 1 |
| Kodama, M | 1 |
| Aizawa, Y | 1 |
| Yamaguchi, K | 1 |
| Miyazaki, M | 1 |
| Kakemi, M | 1 |
| Moyer-Knox, D | 1 |
| Mueller, TM | 1 |
| Vuckovic, K | 1 |
| Mischke, L | 1 |
| Williams, RE | 1 |
| Ko, DT | 1 |
| Hebert, PR | 1 |
| Coffey, CS | 1 |
| Curtis, JP | 1 |
| Foody, JM | 1 |
| Sedrakyan, A | 1 |
| Krumholz, HM | 1 |
| Earl, GL | 1 |
| Verbos-Kazanas, MA | 1 |
| Fitzpatrick, JM | 1 |
| Narula, J | 1 |
| Vural, M | 1 |
| Fett, JD | 1 |
| Hantson, P | 1 |
| Lambermont, JY | 1 |
| Simoens, G | 1 |
| Mahieu, P | 1 |
| Cleophas, TJ | 1 |
| van der Meulen, J | 1 |
| van de Luit, L | 1 |
| Zwinderman, AH | 1 |
| Lindenfeld, J | 1 |
| Lowes, BD | 1 |
| Bristow, MR | 1 |
| Forrest, E | 1 |
| Stanley, A | 1 |
| Hayes, P | 1 |
1 review available for carvedilol and Blood Pressure, Low
| Article | Year |
|---|---|
Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Bradycardia; Carvedilol; Dermatologic Agents; Dru | 2020 |
2 trials available for carvedilol and Blood Pressure, Low
| Article | Year |
|---|---|
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatig | 2004 |
Daytime-selective antihypertensive activity of celiprolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme | 1999 |
19 other studies available for carvedilol and Blood Pressure, Low
| Article | Year |
|---|---|
Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1.
Topics: 2-Propanol; Adrenergic Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electroca | 2009 |
Effect of Beta-Blocker Cardioselectivity on Vascular Refilling in Hemodialysis Patients.
Topics: Adrenergic beta-Antagonists; Carvedilol; Cross-Over Studies; Humans; Hypotension; Prospective Studie | 2021 |
Comparison of new-onset post-operative atrial fibrillation between patients receiving carvedilol and metoprolol after off-pump coronary artery bypass graft surgery.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Bradycardia; Carvedilol; Coronary Artery By | 2023 |
Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Dizziness; Dose-Response Rela | 2013 |
Altered responses to vasopressors of a patient medicated with carvedilol, pilsicainide and enalapril.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atria | 2014 |
Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Bradycardia; Carbazoles; Cardiac Resynchronizatio | 2016 |
Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Carbazoles; Carvedilol; Drug Monitoring; Esophageal and | 2017 |
Pediatric carvedilol ingestions reported to Texas poison centers, 2000 to 2008.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Child, Preschool; Combined Modality Therapy; Fe | 2010 |
Angiotensin-receptor-blocker-induced refractory hypotension responds to methylene blue.
Topics: Aged; Angiotensin Receptor Antagonists; Carbazoles; Carvedilol; Citalopram; Crystalloid Solutions; D | 2012 |
[Use of carvedilol in daily practice].
Topics: Adrenergic beta-Antagonists; Bradycardia; Carbazoles; Cardiology; Carvedilol; Coronary Disease; Drug | 1999 |
Contribution of sympathetic nervous system activity during administration of carvedilol in rats with dilated cardiomyopathy.
Topics: Animals; Blood Pressure; Body Weight; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dose-Response | 2003 |
Remote titration of carvedilol for heart failure patients by advanced practice nurses.
Topics: Adrenergic beta-Antagonists; Aged; Bradycardia; Carbazoles; Carvedilol; Clinical Protocols; Cohort S | 2004 |
Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Blood Pressure; Carbazoles; Cardiac Output, | 2007 |
[Role of the drug interaction between carvedilol and dobutamine in inducing of severe hypotension in a case with acute coronary syndrome].
Topics: Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Diagnosis, Differential; Dobutamine; Drug Interact | 2007 |
Case 36-2007: a woman with rash, fever, and hypotension.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Female; Humans; Hypotensi | 2008 |
Carvedilol overdose.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Carbazoles; Carvedilol; Dopamine; Drug Overdose; Electr | 1997 |
Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Cardiac Ou | 1999 |
Carvedilol--A new nonselective beta blocker.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Hemodynamics; Humans; Hypotension; Liver Cirrho | 2000 |
Beta-blockers for heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Heart Failure; Humans; | 2000 |